Trials / Completed
CompletedNCT04477096
Evaluation of Drug Interaction Between HS-10234 and Emtriccitabine
Study on the Drug Interaction of HS-10234 and Emtricitabine in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The study is being conducted to evaluate drug interaction between HS-10234 and Emtricitabine after multiple dose in healthy subjects.
Detailed description
The study includes two parts. Part 1 is to evaluate the impact of Emtricitabine on HS-10234. Part 2 is to evaluate the impact of HS-10234 on Emtricitabine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HS-10234 | HS-10234 |
| DRUG | Emtricitabine | Emtricitabine |
Timeline
- Start date
- 2020-08-03
- Primary completion
- 2020-09-24
- Completion
- 2020-09-24
- First posted
- 2020-07-20
- Last updated
- 2020-10-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04477096. Inclusion in this directory is not an endorsement.